Actively Recruiting
Fabhalta Capsules Specified Drug-use Survey
Led by Novartis Pharmaceuticals · Updated on 2026-04-13
50
Participants Needed
26
Research Sites
145 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to evaluate the safety and effectiveness of Fabhalta in patients with C3 glomerulopathy in clinical practice.
CONDITIONS
Official Title
Fabhalta Capsules Specified Drug-use Survey
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have used Fabhalta for C3 glomerulopathy, including those with recurrent C3 glomerulopathy after kidney transplant
You will not qualify if you...
- Use of iptacopan for indications not approved under the Clinical Trials Act or Good Clinical Practice (e.g., patient-requested treatment or investigator-initiated trial)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 26 locations
1
Novartis Investigative Site
Nagoya, Aichi-ken, Japan, 466-8650
Actively Recruiting
2
Novartis Investigative Site
Toyoake, Aichi-ken, Japan, 4701192
Actively Recruiting
3
Novartis Investigative Site
Hirosaki, Aomori, Japan, 036 8563
Actively Recruiting
4
Novartis Investigative Site
Chiba, Chiba, Japan, 2608677
Actively Recruiting
5
Novartis Investigative Site
Kitakyushu, Fukuoka, Japan, 8028555
Actively Recruiting
6
Novartis Investigative Site
Sapporo, Hokkaido, Japan, 0040041
Actively Recruiting
7
Novartis Investigative Site
Sapporo, Hokkaido, Japan, 060-8604
Actively Recruiting
8
Novartis Investigative Site
Tsukuba, Ibaraki, Japan, 3058576
Active, Not Recruiting
9
Novartis Investigative Site
Komatsu, Ishikawa-ken, Japan, 923-0961
Active, Not Recruiting
10
Novartis Investigative Site
Tsu, Mie-ken, Japan, 514-8507
Active, Not Recruiting
11
Novartis Investigative Site
Nagasaki, Nagasaki, Japan, 852-8501
Actively Recruiting
12
Novartis Investigative Site
Shimajiri-Gun, Okinawa, Japan, 901-1303
Actively Recruiting
13
Novartis Investigative Site
Suita, Osaka, Japan, 565-0871
Actively Recruiting
14
Novartis Investigative Site
Takatsuki, Osaka, Japan, 5698686
Active, Not Recruiting
15
Novartis Investigative Site
Kusatsu, Shiga, Japan, 525-8585
Actively Recruiting
16
Novartis Investigative Site
Ohtsu, Shiga, Japan, 5202192
Actively Recruiting
17
Novartis Investigative Site
Shimotsuga Gun, Tochigi, Japan, 321-0293
Actively Recruiting
18
Novartis Investigative Site
Tokushima, Tokushima, Japan, 7708503
Actively Recruiting
19
Novartis Investigative Site
Bunkyo-ku, Tokyo, Japan, 1138519
Active, Not Recruiting
20
Novartis Investigative Site
Fuchū, Tokyo, Japan, 1838561
Actively Recruiting
21
Novartis Investigative Site
Nakano City, Tokyo, Japan, 164-8607
Actively Recruiting
22
Novartis Investigative Site
Shinjuku Ku, Tokyo, Japan, 1628666
Actively Recruiting
23
Novartis Investigative Site
Yosa, Yosa, Japan, 629-2261
Active, Not Recruiting
24
Novartis Investigative Site
Hiroshima, Japan, 734 8530
Actively Recruiting
25
Novartis Investigative Site
Nara, Japan, 630-8581
Active, Not Recruiting
26
Novartis Investigative Site
Wakayama, Japan, 640-8558
Active, Not Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here